These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23387316)

  • 1. Diagnostic value of circulating microRNAs for lung cancer: a meta-analysis.
    Shen Y; Wang T; Yang T; Hu Q; Wan C; Chen L; Wen F
    Genet Test Mol Biomarkers; 2013 May; 17(5):359-66. PubMed ID: 23387316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of circulating microRNAs for nasopharyngeal cancer: a systematic review and meta-analysis.
    Wang Z; Chen W; Zhang Y; Xu L; Wang Q
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C173-8. PubMed ID: 25450278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of circulating microRNAs for hepatocellular carcinoma.
    Yang Y; Zhu R
    Mol Biol Rep; 2014 Oct; 41(10):6919-29. PubMed ID: 25030834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accuracy of microRNA-210 in diagnosing lung cancer: a systematic review and meta-analysis.
    Yang H; Wang H; Zhang C; Tong Z
    Oncotarget; 2016 Sep; 7(39):63283-63293. PubMed ID: 27557519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
    Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
    Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
    Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNA-145 as a diagnostic biomarker for non-small-cell lung cancer: A systemic review and meta-analysis.
    Tao S; Ju X; Zhou H; Zeng Q
    Int J Biol Markers; 2020 Dec; 35(4):51-60. PubMed ID: 33103527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis.
    Liu T; Liu D; Guan S; Dong M
    Ann Med; 2021 Dec; 53(1):87-102. PubMed ID: 33108223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as ideal biomarkers for the diagnosis of lung cancer.
    Guo Z; Zhao C; Wang Z
    Tumour Biol; 2014 Oct; 35(10):10395-407. PubMed ID: 25053595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of microRNA-21 in the diagnosis of lung cancer: evidence from a meta-analysis involving 11 studies.
    Wu R; Jiang Y; Wu Q; Li Q; Cheng D; Xu L; Zhang C; Zhang M; Ye L
    Tumour Biol; 2014 Sep; 35(9):8829-36. PubMed ID: 24880588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
    Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
    Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis.
    Zhang R; Shao F; Wu X; Ying K
    Lung Cancer; 2010 Aug; 69(2):225-31. PubMed ID: 20004997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis of the diagnostic value of circulating microRNA-17-5p in patients with non-small cell lung cancer.
    Hao J; Shen Z
    Medicine (Baltimore); 2023 Feb; 102(8):e33070. PubMed ID: 36827064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Yin C; Fang C; Weng H; Yuan C; Wang F
    Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
    Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
    Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited diagnostic value of microRNAs for detecting colorectal cancer: a meta-analysis.
    Zhou XJ; Dong ZG; Yang YM; Du LT; Zhang X; Wang CX
    Asian Pac J Cancer Prev; 2013; 14(8):4699-704. PubMed ID: 24083729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.